Taking into consideration the facts that gonadotropin signaling is the root to promote ovarian cancer progression and that the thyrostimulin-TSHR pair evolved much earlier than the gonadotropin signaling systems, we thus hypothesize that thyrostimulin-TSHR signaling is likely to be involved in ovarian cancer progression. This evidence concerns the gene TSHR and ovarian carcinoma.